Literature DB >> 25545680

Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.

Ling Lei1, Zhi-Yi He2, Cheng Zhao1, Xue-Jiao Sun2, Xiao-Ning Zhong2.   

Abstract

AIM: Systemic sclerosis (SSc) is characterized by immune abnormalities, progressive fibrosis of the skin and internal organs, and microvascular injury and damage. Interleukin-21 receptor (IL-21R) is expressed in the epidermis from patients with SSc. However, information describing the role of IL-21 in SSc is limited.
METHODS: We established a mouse model of bleomycin (BLM)-induced fibrosis. The frequency of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells in peripheral blood, skin and lungs of BLM-induced mice were detected by flow cytometry; IL-21 levels in the peripheral blood were evaluated by enzyme-linked immunosorbent assay (ELISA). CD4(+) T cells were isolated from the spleen of BLM-induced and control mice and cultured in vitro alone or in the presence of mrIL-21 or mrIL-21 plus transforming growth factor (TGF)-β1. The frequency of Th17 cells was detected by flow cytometry; levels of IL-17 were evaluated by ELISA, and the expression of IL-17A and retinoic-acid-receptor-related orphan receptors gamma t (RORγt) messenger RNA were analyzed by real-time polymerase chain reaction.
RESULTS: Compared to control mice, the frequency of CD4(+) IL-21(+) T, CD4(+) 21R(+) T and IL-21(+) Th17 cells and the levels of IL-21 were significantly increased in BLM-induced mice. The frequency of CD4(+) IL-21(+) T, CD4(+) 21R(+) T and IL-21(+) Th17 cells and the levels of IL-21 were correlated with dermal and pulmonary inflammation and fibrosis. In vitro analyses indicate that IL-21 promoted the differentiation of Th17 cells from CD4(+) cells isolated from the spleen of BLM-induced mice.
CONCLUSION: IL-21 may play an important role in the pathogenesis of SSc as a Th17 effector cytokine, and IL-21 may induce the differentiation of Th17 cells in the BLM-induced SSc mouse model.
© 2014 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  CD4+T cells; Systemic sclerosis; Th17 cells; interleukin-21; interleukin-21 receptor

Mesh:

Substances:

Year:  2014        PMID: 25545680     DOI: 10.1111/1756-185X.12522

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  5 in total

Review 1.  Interleukin-17 pathways in systemic sclerosis-associated fibrosis.

Authors:  Sakir Ahmed; Durga Prasanna Misra; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2019-05-09       Impact factor: 2.631

2.  Elevated levels of TL1A are associated with disease activity in patients with systemic sclerosis.

Authors:  Wangdong Xu; Linchong Su; Pingying Qing; Ying Wang; Yan Liang; Yi Zhao; Qiongxiu Zhou; Feng Ma; Yi Liu
Journal:  Clin Rheumatol       Date:  2017-04-10       Impact factor: 2.980

3.  Altered Cellular Immunity and Differentially Expressed Immune-Related Genes in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.

Authors:  Jianxin Tu; Jinji Jin; Xiaowei Chen; Li Sun; Zhen Cai
Journal:  Front Immunol       Date:  2022-05-18       Impact factor: 8.786

4.  Carbenoxolone decreases monocrotaline‑induced pulmonary inflammation and pulmonary arteriolar remodeling in rats by decreasing the expression of connexins in T lymphocytes.

Authors:  Liang Ζ Zhang; Zhi-Ru Fan; Lu Wang; Lu-Qian Liu; Xin-Zhi Li; Li Li; Jun-Qiang Si; Ke-Tao Ma
Journal:  Int J Mol Med       Date:  2019-11-13       Impact factor: 4.101

5.  IFN-γ+ IL-17+ Th17 cells regulate fibrosis through secreting IL-21 in systemic scleroderma.

Authors:  Xiaojing Xing; Anqi Li; Hong Tan; Yong Zhou
Journal:  J Cell Mol Med       Date:  2020-11-06       Impact factor: 5.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.